In monocytes and NK cells, the MUC16-STn antigen-Siglec-9 ternary complex activates the immune checkpoint network, inhibiting NK cell activation and correlating with reduced ovarian cancer patient survival. Here, MUC16 is linked to ovarian carcinoma.